6533b829fe1ef96bd128ac1d
RESEARCH PRODUCT
Understanding mechanisms of primary resistance to checkpoint inhibitors will lead to precision immunotherapy of advanced gastric cancer
Valentina GambardellaT. FleitasAndrés Cervantessubject
OncologyImmunologic Factorsbusiness.industrymedicine.medical_treatmentImmune checkpoint inhibitorsCancer researchmedicineHematologyImmunotherapyAdvanced gastric cancerbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2019-03-01 | Annals of Oncology |